Skip to main content

ReLive Biotechnologies LTD

Newton, United States

ReLive is spearheading regenerative cell therapies to address unmet needs in the areas of orthopedic sports medicine and plastic surgery.

$43.0M raised
Jan 2023
Series A

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ReLive Biotechnologies LTD

How much funding has ReLive Biotechnologies LTD raised?
ReLive Biotechnologies LTD has raised $43.0M in total funding. The most recent round was Series A. The last funding was announced in January 2023.
Who are ReLive Biotechnologies LTD's investors?
ReLive Biotechnologies LTD's investors include Shanghai Healthcare Capital, Indaco Capital, Jiuyou Capital.
Where is ReLive Biotechnologies LTD headquartered?
ReLive Biotechnologies LTD is headquartered in Newton, United States.
What does ReLive Biotechnologies LTD do?
ReLive is spearheading regenerative cell therapies to address unmet needs in the areas of orthopedic sports medicine and plastic surgery.
What stage is ReLive Biotechnologies LTD at?
ReLive Biotechnologies LTD is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"ReLive Biotechnologies LTD — Funding & Investors." VCBacked, January 16, 2023, https://www.vcbacked.co/company/relive-biotechnologies-ltd. Accessed July 2, 2026.
APA
VCBacked. (2023). ReLive Biotechnologies LTD — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/relive-biotechnologies-ltd
Wikipedia (cite web)
{{cite web |title=ReLive Biotechnologies LTD — Funding & Investors |url=https://www.vcbacked.co/company/relive-biotechnologies-ltd |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .